Dr. Gottesdiener is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Rhythm Pharmaceuticals
855 Boylston Street, 11th Floor
Boston, MA 02116Phone+1 857-264-4280- Is this information wrong?
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1985 - 1988
- Brigham and Women's HospitalResidency, Internal Medicine, 1982 - 1985
- Perelman School of Medicine at the University of PennsylvaniaClass of 1982
Certifications & Licensure
- MA State Medical License 1984 - 2025
- CT State Medical License 1985 - 2025
- NY State Medical License 1988 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 177 citationsMC4R agonism promotes durable weight loss in patients with leptin receptor deficiencyKarine Clément, Heike Biebermann, I. Sadaf Farooqi, Lex H.T. Van der Ploeg, Barbara Wolters, Christine Poitou, Lia Puder, Fred T. Fiedorek, Keith Gottesdiener, Gunnar ...> ;Nature Medicine. 2018 May 1
- 43 citationsMelanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist TreatmentKristin L. Ayers, Benjamin S. Glicksberg, Alastair S Garfield, Simonne Longerich, Joseph A White, Pengwei Yang, Lei Du, Thomas Chittenden, Jeffery R Gulcher, Sophie Ro...> ;The Journal of Clinical Endocrinology and Metabolism. 2018 Jul 1
- 93 citationsEfficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled StudyMichael Camilleri, Richard W. McCallum, Jan Tack, Sharon C. Spence, Keith Gottesdiener, Fred T. Fiedorek> ;Gastroenterology. 2017 Nov 1
- Join now to see all
Press Mentions
- Prime Medicine Appoints Ann L. Lee as Chief Technical OfficerOctober 13th, 2021
- Chutes & Ladders—Biogen CFO Capello Steps down from Role Amid M&A SpeculationJuly 24th, 2020
- A Wobbly Biogen Makes a Surprise Switch in the Executive Suite, Triggering a Renewed Burst of M&A ChatterJuly 22nd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: